Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)

ClinicalTrials.gov ID: NCT03620357

Public ClinicalTrials.gov record NCT03620357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Continuous Glucose Monitoring & Management In Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Study to assess if patients with Type 2 diabetes (T2D) who have suboptimal glycemic control using multiple oral agents are able to make lifestyle changes resulting in improved glycemic control by use of real-time continuous glucose monitoring (RT-CGM) and targeted learning modules versus self monitored blood glucose (SMBG) testing.

Study identification

NCT ID
NCT03620357
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
DexCom, Inc.
Industry
Enrollment
72 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 4, 2018
Primary completion
May 26, 2020
Completion
Nov 3, 2020
Last update posted
Mar 21, 2021

2018 – 2020

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Diabetes/Lipid Management and Research Center Huntington Beach California 92648
Temecula Valley Endocrinology Temecula California 92592
Atlanta Diabetes Associates Atlanta Georgia 30318
MODEL Clinical Research (Towson) Baltimore Maryland 21204
Diabetes & Endocrine Associates, PC Omaha Nebraska 68114
Las Vegas Endocrinology Henderson Nevada 89052
The Docs Las Vegas Nevada 89113
Palm Research Center Las Vegas Nevada 89148
Diabetes and Glandular Disease Clinic San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03620357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03620357 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →